SureTrader
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

$120 per share for NAVB? Let the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
casperboo Member Profile
 
Followed By 6
Posts 1,246
Boards Moderated 1
Alias Born 02/13/10
160x600 placeholder
Navidea Biopharmaceuticals to Present at 2016 BIO CEO & Investor Conference "Business Wire" - 2/4/2016 9:21:00 AM
Navidea Provides Update on Lymphoseek® and Immunodiagnostics Development Pipeline "Business Wire" - 2/2/2016 5:07:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/11/2016 12:33:25 PM
Navidea Meets Guidance With 2015 Unaudited Lymphoseek® Sales of $10.2 Million "Business Wire" - 1/11/2016 6:45:00 AM
Navidea Appoints Anton Gueth Chairman of the Board "Business Wire" - 1/11/2016 6:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/8/2016 5:32:47 PM
Navidea Biopharmaceuticals Enrolls First Patient in Pediatric Trial of Lymphoseek® "Business Wire" - 1/6/2016 7:30:00 AM
Navidea Biopharmaceuticals to Present at Biotech Showcase 2016 "Business Wire" - 1/4/2016 7:30:00 AM
Lymphoseek® Technically Successful in Evaluation of Sentinel Lymph Node Biopsy in Patients Undergoing Neoadjuvant Chemotherapy "Business Wire" - 12/10/2015 4:30:00 PM
Lymphoseek® Reduces Sentinel Lymph Node Biopsy Imaging Time, Facilitating Patient Throughput and Workflow Efficiencies "Business Wire" - 12/3/2015 8:29:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/3/2015 4:21:58 PM
Navidea Biopharmaceuticals to Present at Stifel 2015 Healthcare Conference "Business Wire" - 11/10/2015 7:30:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/9/2015 5:58:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/6/2015 5:07:51 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/4/2015 4:50:57 PM
Navidea Reports 2015 Third Quarter Financial Results "Business Wire" - 11/4/2015 7:30:00 AM
Navidea Biopharmaceuticals to Announce Third Quarter 2015 Financial Results on November 4, 2015 "Business Wire" - 10/26/2015 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/20/2015 12:13:31 PM
Navidea Biopharmaceuticals to Present at BIO Investor Forum "Business Wire" - 10/14/2015 7:30:00 AM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 10/9/2015 4:14:51 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/5/2015 6:03:21 PM
Navidea Biopharmaceuticals Announces Addition to Major Indexes on Tel Aviv Stock Exchange "Business Wire" - 9/28/2015 7:30:00 AM
Macrophage Therapeutics Produces First Two Immunoconstructs "Business Wire" - 9/25/2015 7:30:00 AM
Navidea Biopharmaceuticals to Present at the Ladenburg Thalmann 2015 Healthcare Conference "Business Wire" - 9/17/2015 7:30:00 AM
Navidea Awarded $1.8M Fast Track NIH SBIR Grant for Evaluation of a Manocept™ Agent in Kaposi’s Sarcoma "Business Wire" - 9/3/2015 7:30:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist